OKYO Pharma Limited Ordinary Shares — Quarterly Financial Statements (NASDAQ:OKYO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Market Capitalization 62.06 M
Employee 4
Founded 2007
CEO N/A
Website www.okyopharma.com
Headquarter United Kingdom
FIGI UNKNOWN
Industry Technology

62.06 M Market capitalization

News

Piper Sandler initiates OKYO Pharma stock with Overweight rating

OKYO Pharma stock tumbles on $20 million public offering announcement

OKYO Pharma announces $20 million public offering of ordinary shares

OKYO Pharma transitions ATM equity offering to Leerink Partners as sales agent

OKYO Pharma appoints former Dompé CMO Flavio Mantelli to lead NCP program

OKYO Pharma to present urcosimod NCP study results at ASCRS meeting

H.C. Wainwright reiterates Buy rating on OKYO Pharma stock with $7 price target

OKYO Pharma stock rises after FDA confirms Phase 2b/3 trial design

OKYO Pharma reports successful FDA meeting on urcosimod clinical trial

OKYO Pharma receives FDA alignment on Phase 2b/3 trial for NCP treatment

OKYO Pharma stock gets FDA compassionate use approval for urcosimod

FDA authorizes compassionate use of urcosimod for neuropathic corneal pain